Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation.
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D008271:Mycetoma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D009894:Opportunistic Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D018570:Risk Assessment; D021681:Scedosporium / Q000187:drug effects* / Q000302:isolation & purification; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014230:Triazoles / Q000627:therapeutic use*; D065819:Voriconazole
D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole